Efficacy and safety of HER2-ADC SHR-A1811 in HER2-positive breast cancer with brain metastases.
Min Yan(Xi'an University of Science and Technology), Ruoyu Huang(Beihang University), Limin Niu(Zhengzhou University), Huihui Sun(Zhengzhou University), Yaowen Cui(Zhengzhou University), Zhenzhen Liu(Jilin University), Jing Wang(Zhengzhou University), Shengnan Zhao(Zhengzhou University), Mengwei Zhang(Zhengzhou University), Huimin Lv(Zhengzhou University), Yajing Feng(Zhengzhou University), Huiai Zeng(Zhengzhou University)
Cited by 5
Related Papers
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
|The Lancet Respiratory Medicine|2018|477
Molecular simulation of the competitive adsorption characteristics of CH4, CO2, N2, and multicomponent gases in coal
|Powder Technology|2021|134